1. Home
  2. ACR vs EQ Comparison

ACR vs EQ Comparison

Compare ACR & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACR

ACRES Commercial Realty Corp.

HOLD

Current Price

$20.29

Market Cap

141.1M

Sector

Real Estate

ML Signal

HOLD

EQ

Equillium Inc.

HOLD

Current Price

$2.08

Market Cap

129.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACR
EQ
Founded
2005
2017
Country
United States
United States
Employees
4
14
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.1M
129.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ACR
EQ
Price
$20.29
$2.08
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$24.50
$8.00
AVG Volume (30 Days)
10.7K
400.2K
Earning Date
04-29-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$41,095,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.06
$0.29
52 Week High
$24.61
$2.70

Technical Indicators

Market Signals
Indicator
ACR
EQ
Relative Strength Index (RSI) 67.25 51.18
Support Level $18.71 $1.60
Resistance Level $21.27 $2.13
Average True Range (ATR) 0.34 0.21
MACD 0.06 0.01
Stochastic Oscillator 70.16 43.40

Price Performance

Historical Comparison
ACR
EQ

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding, and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralized debt obligations, and private equity investments mainly issued by financial institutions.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: